X

Sign up for Equitymaster's free daily newsletter, The 5 Minute WrapUp and get access to our latest Multibagger guide (2018 Edition) on picking money-making stocks.

This is an entirely free service. No payments are to be made.


Download Now Subscribe to our free daily e-letter, The 5 Minute WrapUp and get this complimentary report.
We hate spam as much as you do. Check out our Privacy Policy and Terms Of Use.
Compare Sterling Biotech with PLETHICO PHARMA - Equitymaster

Helping You Build Wealth With Honest Research
Since 1996. Try Now

  • MyStocks

MEMBER'S LOGINX

     
Login Failure
   
     
   
     
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

STERLING BIOTECH vs PLETHICO PHARMA - Comparison Results

STERLING BIOTECH    Change

Sterling Biotech primarily produces and distributes pharmaceutical grade gelatine globally. The company currently has a 7.5% share of the global market for pharmaceutical and nutraceutical gelatines. It has more than 70% market share in India. Sterli... More

DO YOU LIKE THESE REPORTS? TELL US!

Current Valuations

    STERLING BIOTECH PLETHICO PHARMA STERLING BIOTECH/
PLETHICO PHARMA
 
P/E (TTM) x -0.4 -1.1 - View Chart
P/BV x 0.0 0.0 82.8% View Chart
Dividend Yield % 0.0 0.0 -  

Financials

 STERLING BIOTECH   PLETHICO PHARMA
EQUITY SHARE DATA
    STERLING BIOTECH
Dec-13
PLETHICO PHARMA
Mar-14
STERLING BIOTECH/
PLETHICO PHARMA
5-Yr Chart
Click to enlarge
High Rs11395 2.7%   
Low Rs331 10.9%   
Sales per share (Unadj.) Rs26.8604.4 4.4%  
Earnings per share (Unadj.) Rs-15.032.5 -46.1%  
Cash flow per share (Unadj.) Rs-5.551.3 -10.6%  
Dividends per share (Unadj.) Rs00-  
Dividend yield (eoy) %00-  
Book value per share (Unadj.) Rs54.9473.6 11.6%  
Shares outstanding (eoy) m267.8734.08 786.0%   
Bonus/Rights/Conversions ---  
Price / Sales ratio x0.30.4 73.5%   
Avg P/E ratio x-0.56.6 -7.1%  
P/CF ratio (eoy) x-1.34.2 -30.6%  
Price / Book Value ratio x0.10.5 28.1%  
Dividend payout %00-   
Avg Mkt Cap Rs m1,8627,262 25.6%   
No. of employees `0001.4NA-   
Total wages/salary Rs m5471,596 34.3%   
Avg. sales/employee Rs Th5,303.3NM-  
Avg. wages/employee Rs Th403.8NM-  
Avg. net profit/employee Rs Th-2,959.0NM-  
INCOME DATA
Net Sales Rs m7,18120,598 34.9%  
Other income Rs m43386 11.0%   
Total revenues Rs m7,22320,984 34.4%   
Gross profit Rs m9472,818 33.6%  
Depreciation Rs m2,543642 396.0%   
Interest Rs m4,3771,593 274.7%   
Profit before tax Rs m-5,931969 -612.4%   
Minority Interest Rs m00-   
Prior Period Items Rs m00-   
Extraordinary Inc (Exp) Rs m00-   
Tax Rs m-1,924-138 1,390.6%   
Profit after tax Rs m-4,0071,107 -362.0%  
Gross profit margin %13.213.7 96.4%  
Effective tax rate %32.4-14.3 -227.1%   
Net profit margin %-55.85.4 -1,038.3%  
BALANCE SHEET DATA
Current assets Rs m14,33518,877 75.9%   
Current liabilities Rs m49,80911,896 418.7%   
Net working cap to sales %-494.033.9 -1,457.8%  
Current ratio x0.31.6 18.1%  
Inventory Days Days40336 1,122.5%  
Debtors Days Days171198 86.3%  
Net fixed assets Rs m55,4329,861 562.2%   
Share capital Rs m268341 78.6%   
"Free" reserves Rs m13,93512,331 113.0%   
Net worth Rs m14,70116,139 91.1%   
Long term debt Rs m9,4784,706 201.4%   
Total assets Rs m73,98833,146 223.2%  
Interest coverage x-0.41.6 -22.1%   
Debt to equity ratio x0.60.3 221.1%  
Sales to assets ratio x0.10.6 15.6%   
Return on assets %0.58.1 6.1%  
Return on equity %-27.36.9 -397.4%  
Return on capital %-6.412.3 -52.3%  
Exports to sales %25.921.4 121.2%   
Imports to sales %0.215.2 1.1%   
Exports (fob) Rs m1,8604,402 42.2%   
Imports (cif) Rs m123,136 0.4%   
Fx inflow Rs m1,8604,402 42.2%   
Fx outflow Rs m253,184 0.8%   
Net fx Rs m1,8351,219 150.6%   
CASH FLOW
From Operations Rs m1,7192,437 70.5%  
From Investments Rs m-3,148-6,265 50.3%  
From Financial Activity Rs m1,4262,490 57.3%  
Net Cashflow Rs m-3-1,337 0.3%  

Share Holding

Indian Promoters % 33.9 82.7 41.0%  
Foreign collaborators % 0.0 0.0 -  
Indian inst/Mut Fund % 0.0 4.3 -  
FIIs % 9.9 5.5 180.0%  
ADR/GDR % 16.9 0.0 -  
Free float % 39.3 7.5 524.0%  
Shareholders   21,482 10,665 201.4%  
Pledged promoter(s) holding % 55.9 85.7 65.2%  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster

Compare STERLING BIOTECH With:   ELDER PHARMA  FDC LTD.  SUN PHARMA  STRIDES SHASUN LTD  TTK HEALTHCARE  

Compare STERLING BIOTECH With:   MYLAN (US)  ACTAVIS (US)  ADCOCK INGRAM (S. Africa)  TEVA PHARMA (Israel)  



Today's Market

Sensex Ends 383 Points Lower; Realty and Auto Stocks Drag(Closing)

After trading on a volatile note throughout the day, share markets in India witnessed selling pressure during the closing hours and ended the day in red.

Related Views on News

Galaxy Surfactants Ltd. (IPO)

Jan 27, 2018

Should you subscribe to the IPO of Galaxy Surfactants Ltd?

Galaxy Surfactants Ltd. (IPO)

Jan 27, 2018

Should you subscribe to the IPO of Galaxy Surfactants Ltd?

Tata Chem: Suspension of Haldia Operations Drag Bottomline Lower (Quarterly Results Update - Detailed)

Aug 17, 2017

Interruption at Haldia plant and fire at Lostock facility hits operations during the quarter.

Tata Chem: Suspension of Haldia Operations Drag Bottomline Lower (Quarterly Results Update - Detailed)

Aug 17, 2017

Interruption at Haldia plant and fire at Lostock facility hits operations during the quarter.

More Views on News

Most Popular

Don't Panic in This Falling Market... Do This Instead(The 5 Minute Wrapup)

Oct 5, 2018

Find companies with long term durable moats, which are correcting with the current broader market sell-off.

Taxpayers to pay salaries of CEOs/CIOs of Mutual Funds(The Honest Truth)

Oct 5, 2018

Ajit Dayal on the crisis in the market and in the mutual fund industry.

This Market Crash could be the Biggest Wealth Creating Opportunity Since 2008(Profit Hunter)

Oct 8, 2018

While widespread fear is the friend of a value investor, serving up bargain purchases; personal fear is an investor's biggest enemy.

IPO Market Feels the Heat of the Market Crash(Sector Info)

Oct 12, 2018

The sentiments in primary market have also deteriorated amid the stock market correction. Most listed IPOs of 2018 are trading below their issue price.

Are These Deep Corrections a Buying Signal?(Chart Of The Day)

Oct 5, 2018

The correction has bought many good companies to reasonable valuations. Go against the wisdom of crowd and Buy.

More

Small Investments
BIG Returns

Zero To Millions Guide 2018
Get our special report, Zero To Millions
(2018 Edition) Now!
We will never sell or rent your email id.
Please read our Terms

STERLING BIOTECH SHARE PRICE


Oct 15, 2018 (Close)

TRACK STERLING BIOTECH

  • Track your investment in STERLING BIOTECH with Equitymaster's Portfolio Tracker. Set live price alerts, get research alerts and more. Get access now...
  • Add To MyStocks

MORE ON STERLING BIOTECH

STERLING BIOTECH - DISHMAN PHARMA COMPARISON

COMPARE STERLING BIOTECH WITH

MARKET STATS